CBIO
Crescent BiopharmaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
CBIO vs peer average
38/100
CBIO vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 4 · D 1 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
PRLD is the first available peer comparator.
Small-cap clinical-stage oncology biotech peer; useful for comparing early pipeline valuation sensitivity to trial starts and first proof-of-concept data.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CBIO
Crescent Biopharma
PRLD
Prelude Therapeutics
Grade
D
D
Momentum
13
81
Value
41
41
Sentiment
72
30
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs PRLD
CBIO / PRLD
Grade Position
Below peers
CBIO vs. peer average (D vs. C)
38/100
Momentum
13
PRLDValue
41
CBIOSentiment
72
CBIORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CBIO
PRLD is the first peer returned for this comparison set.